|
|
Medication-Assisted Treatment
Part 3: Implementation Challenges and Strategies
1. Medication Assisted Treatment for Special Populations (2012). Addiction Technology Transfer Center (on-line course); Substance Abuse and Mental Health Administration (SAMHSA), Center for Substance Abuse Treatment (CSAT). http://www.attcelearn.org/
2. Treatment Improvement Protocol (TIP) Series No. 43: Medication-Assisted Treatment for Opioid Addiction in Opioid Treatment Programs. SAMHSA, CSAT, SAMHSA (2005); Chapter1, pg. 5. http://store.samhsa.gov/product/TIP-43-Medication-Assisted-Treatment-for-Opioid-Addiction-in-Opioid-Treatment-Programs/SMA12-4214
3. Distance Traveled and Cross-State Commuting to Opioid Treatment Programs in the United States. Rosenblum A, et al; Journal of Environmental and Public Health, 2011; 2011: 948789. Published online July 6, 2011. http://www.hindawi.com/journals/jeph/2011/948789/4. An Introduction to Extended-Release Injectable Naltrexone for the Treatment of People With Opioid Dependence. SAMHSA Advisory (Winter 2012); v.11:1. http://store.samhsa.gov/product/An-Introduction-to-Extended-Release-Injectable-Naltrexone-for-the-Treatment-of-People-with-Opioid-Dependence/SMA12-4682
5. NIATx: Getting Started with Medication-Assisted Treatment with Lessons from Advancing Recovery. Clark L, et al; Network for the Improvement of Addiction Treatment, University of Wisconsin–Madison (2010). http://www.niatx.net/PDF/NIATx-MAT-Toolkit.pdf
6. Using medication-assisted treatment for substance use disorders: Evidence of barriers and facilitators of implementation. Roman PM, Abraham AJ, Knudsen HK; Addictive Behaviors 36 (2011) 584-589. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3087632/?tool=pubmed
 |